<!DOCTYPE html>
<html lang="en">

    <head>
        <meta charset="UTF-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">
        <title>Casebook</title>
        <link rel="stylesheet" href="assets/css/bootstrap.min.css">
        <link rel="stylesheet" href="assets/css/style.css">
        
        <meta name="robots" content="noindex,nofollow">


    </head>

    <body class="hide">

        <div class="modal" tabindex="-1" role="dialog">
            <div class="modal-dialog modal-dialog-centered" id="PasswordModal" role="document">
                <div class="modal-content">
                    <div class="modal-body text-white">
                        <div class="landing-modal">
                            <p class="text-center">
                                This learning program is intended for <br> healthcare professionals only. 
                            </p>
                            <form action="#" class="d-flex flex-column mt-3 pt-1">
                                <label class="mb-1" for="password">Password</label>
                                <input id="password" type="password" value="1234">
                                <label class="mb-1 d-none" id="bad-password">Bad password!</label>
                                <input type="submit" value="Submit">
                            </form>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <header class="bg-white">
            <div class="container d-flex justify-content-between align-items-center">
                <div class="menu-icon d-md-none">
                    <img src="assets/images/icons/menu-open.svg" alt="">
                    <img src="assets/images/icons/menu-close.svg" alt="">
                </div>
                <a href="index.html" class="logo">
                    <img src="assets/images/logo.svg" alt="">
                </a>
                <p class="text-center text-pink text-bold d-md-block d-none">
                    <span class="d-block text-deeppink">
                        casebook on Comorbidities in RA:
                    </span>
                    A Patient-focused Multidisciplinary Perspective
                </p>
                <div class="language d-flex align-items-center">
                    <a class="" href="index.html">
                        <img class="me-2 d-none d-md-block" src="assets/images/icons/home.svg" alt="">
                    </a>
                    <a class="language-switcher" href="#">
                    <span class="text-deeppink pt-0 pt-md-1 pt-lg-2">
                        Fr
                    </span>
                </a>
                </div>
            </div>
        </header>
        <section class="wrapper paitent-content">
            <div class="container d-flex flex-wrap justify-content-between">
                <div class="left-sidebar text-center">
                    <ul>
                        <li>
                            <a class="pink-button" href="case-studies.html">
                                Case studies
                            </a>
                        </li>
                        <li>
                            <a class="pink-button knowledge-test" href="#">
                                Knowledge tests
                            </a>
                        </li>
                        <li>
                            <a class="pink-button reference-button" href="#">
                                References
                            </a>
                        </li>
                        <li>
                            <a class="pink-button" href="events.html">
                                Events
                            </a>
                        </li>
                        <li>
                            <a class="pink-button" href="associations.html">
                                Associations
                            </a>
                        </li>
                        <li>
                            <a class="pink-button" href="about-section.html">
                                About Section 2/3 credit
                            </a>
                        </li>
                        <li class="d-none d-md-block">
                            <a class="pink-button" target="_blank" href="https://www.surveymonkey.com/r/RAcasebook">
                                Evaluation form
                                <span class="d-block mb-1">
                                    (for self-directed learning participants only)
                                </span>
                            </a>
                        </li>
                    </ul>
                </div>
                <div class="middle-content">
                    <div class="row mb-4 pb-1">
                        <div class="col-lg-3 col-sm-6">
                            <a href="allison.html" class="person text-center text-black">
                                <img src="assets/images/1.png" alt="">
                                <p class="text-bold">
                                    Allison G.
                                </p>
                                <p class="text-deeppink text-12">
                                    53-year-old female with RA and risk factors for MACE
                                </p>
                            </a>
                        </div>
                        <div class="col-lg-3 col-sm-6">
                            <a href="luciana.html" class="active person text-center text-black">
                                <img src="assets/images/2.png" alt="">
                                <p class="text-bold">
                                    Luciana P.
                                </p>
                                <p class="text-deeppink text-12">
                                    56-year-old female with RA and metabolic syndrome
                                </p>
                            </a>
                        </div>
                        <div class="col-lg-3 col-sm-6">
                            <a href="robert.html" class="person text-center text-black">
                                <img src="assets/images/3.png" alt="">
                                <p class="text-bold">
                                    Robert L.
                                </p>
                                <p class="text-deeppink text-12">
                                    56-year-old male with RA and history of malignancy
                                </p>
                            </a>
                        </div>
                        <div class="col-lg-3 col-sm-6">
                            <a href="caroline.html" class="person text-center text-black">
                                <img src="assets/images/4.png" alt="">
                                <p class="text-bold">
                                    Caroline P.
                                </p>
                                <p class="text-deeppink text-12">
                                    60-year-old female with RA and fibromyalgia
                                </p>
                            </a>
                        </div>
                    </div>
                    <div class="box-item p-0 pb-4 profile-box">
                        <div class="p-3 p-sm-4 pb-2">
                            <div class="d-flex mb-4 align-items-center">
                                <img src="assets/images/2.png" alt="">
                                <div class="ms-2 ps-1">
                                    <h3 class="common-title">
                                        Luciana P.
                                    </h3>
                                    <p class="text-14 text-deeppink">
                                        56-year-old female with RA and metabolic syndrome
                                    </p>
                                </div>
                            </div>
                            <p class="mb-2">
                                Luciana is a 56-year-old Hispanic female nurse. She is 158 centimetres tall and weighs 90
                                kilograms. She is obese, with a BMI of 36.1 kg/m<sup>2</sup> and is in menopause. Due to her
                                job
                                requirements, Luciana does not get a chance to participate in regular physical activity. Her
                                job involves a lot of standing, walking, and lifting patients. Luciana tries to cook and
                                bring lunch to work, but she eats at the hospital cafeteria most of the time. She has a
                                fatty liver, and her BP is typically measured at 135/90 mmHg. Luciana’s fasting glucose
                                level is 6.0 mmol/L (borderline hyperglycemia). She has high triglycerides (1.8 mmol/L) and
                                low HDL-C levels (1.0 mmol/L). Her creatinine is elevated at 135 µmol/L (normal = 100).
                                Luciana was a heavy smoker but successfully quit one year ago. Her mother had type 2
                                diabetes. Luciana is currently taking a statin and a diuretic, beta blocker and ACE
                                inhibitor. She has had RA for six years and is being treated with methotrexate +
                                hydroxychloroquine.
                            </p>
                        </div>
                        <img src="assets/images/home/6.jpg" alt="">
                    </div>
                    <div class="box-item diff-1 profile-box">
                        <h3 class="common-title text-deeppink mb-3 pb-1">
                            Current RA management & level of control/severity
                        </h3>
                        <div class="d-flex mb-4 align-items-center">
                            <img src="assets/images/2.png" alt="">
                            <div class="ms-2 ps-1">
                                <h3 class="common-title">
                                    Luciana P.
                                </h3>
                                <p class="text-14 text-deeppink">
                                    56-year-old female with RA and metabolic syndrome
                                </p>
                            </div>
                        </div>
                        <p class="text-italic mb-3 pb-lg-1">
                            “I recently had a follow-up with my rheumatologist. He counted my tender and swollen joints and
                            asked me to rate how my arthritis affects me on a scale of 0 to 10, and we completed a few other
                            forms and tests.”
                        </p>
                        <p class="mb-3">
                            <strong>
                                His assessment was as follows:
                            </strong>
                        </p>
                        <img src="assets/images/luciana/1.jpg" alt="">
                        <p class="mt-3 pt-1">
                            Luciana’s CDAI is 16.5, indicating moderate inflammatory activity. Her CRP level is slightly
                            elevated.
                        </p>
                    </div>
                    <div class="box-item diff-1">
                        <h3 class="text-deeppink common-title mb-3">
                            Current management approaches and control/severity of metabolic syndrome:
                        </h3>
                        <p class="text-bold mb-3">
                            Considering MTX safety in patients with RA and fatty liver
                        </p>
                        <p class="mb-3">
                            Considering Luciana has a fatty liver, is it safe to use MTX to treat rheumatoid arthritis in
                            Luciana?
                        </p>
                        <ul class="radio-options mt-3 bg-lightgray">
                            <li class="d-flex align-items-center">
                                <input type="radio" id="radio-1" name="question-1" class="me-1">
                                <label for="radio-1">
                                    Yes
                                </label>
                            </li>
                            <li class="d-flex align-items-center">
                                <input type="radio" id="radio-2" name="question-1" class="me-1">
                                <label for="radio-2">
                                    No
                                </label>
                            </li>
                            <li class="d-flex align-items-center right">
                                <input type="radio" id="radio-3" name="question-1" class="me-1">
                                <label for="radio-3">
                                    Depends on more information needed
                                </label>
                            </li>
                        </ul>
                        <div class="text-center mt-4 submit-button-wrapper">
                            <a href="#" class="pink-button">
                                Submit
                            </a>
                        </div>
                        <div class="answer mt-4 d-none">
                            <p class="text-bold">
                                Depends on more information needed
                            </p>
                            <p>
                                In Luciana’s case, it is recommended that a non-invasive alternative to liver biopsy (i.e.,
                                FibroScan<sup>®</sup>) be performed,<sup>1</sup> as patients with metabolic syndrome may
                                experience
                                significant
                                liver fibrosis. If the fibrosis score is F2 (i.e., moderate liver scarring) or less, MTX can
                                be used. However, MTX should be avoided in patients with fibrosis scores above
                                F2.<sup>2</sup>
                            </p>
                        </div>
                    </div>

                    <div class="box-item diff-1">
                        <h3 class="common-title text-deeppink mb-3">
                            Effects of renal impairment and NASH on MTX
                        </h3>
                        <div class="accordion-wrapper">
                            <div class="accordion--items">
                                <div class="accordion--item">
                                    <div class="accordion__title">
                                        <div class="accordion__title__inner">
                                            <h3>
                                                What is the effect of renal impairment and non-alcoholic steatohepatitis
                                                (NASH) on MTX?
                                            </h3>
                                            <img src="assets/images/icons/accordion-title.svg" alt="">
                                        </div>
                                    </div>
                                    <div class="accordion__content" style="height: 0px;">
                                        <div class="accordion__content__inner pt-3">
                                            <p>
                                                Methotrexate dose should be reduced in patients with chronic renal failure,
                                                and NSAIDs should be avoided. Approximately 90% of methotrexate is renally
                                                excreted,<sup>3</sup> and any chronic renal dysfunction could delay the
                                                elimination of
                                                methotrexate. Accordingly, the prolonged presence of methotrexate in plasma
                                                concentration can increase methotrexate-related toxicities.<sup>3</sup> One
                                                study
                                                recommended that the methotrexate dose be reduced by half if the glomerular
                                                filtration rate is &lt;30 mL/min.<sup>4</sup> A FibroScan should be
                                                performed in
                                                patients
                                                with NASH, and if the fibrosis score is F2 or less, methotrexate can be
                                                used. Otherwise, methotrexate should be avoided. If GFR decreases then
                                                MTX dose should be lowered.<sup>3</sup> </p>
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div class="box-item diff-1">
                        <h3 class="common-title text-deeppink mb-3">
                            Alternative medications to MTX in patients with RA
                        </h3>
                        <div class="accordion-wrapper">
                            <div class="accordion--items">
                                <div class="accordion--item">
                                    <div class="accordion__title">
                                        <div class="accordion__title__inner">
                                            <h3>
                                                If MTX should be avoided in a given patient, what should be used
                                                alternatively?
                                            </h3>
                                            <img src="assets/images/icons/accordion-title.svg" alt="">
                                        </div>
                                    </div>
                                    <div class="accordion__content" style="height: 0px;">
                                        <div class="accordion__content__inner pt-3">
                                            <p class="mb-3">
                                                Alternatives to MTX include hydroxychloroquine (which this patient is taking
                                                and on its own is likely too weak to improve her disease activity),
                                                leflunomide and sulfasalazine.<sup>5</sup> In patients with end-stage renal
                                                disease or
                                                with impaired renal function, options include a TNF inhibitor such as the
                                                monoclonal TNF antagonist, infliximab (although the monograph specifies that
                                                no dosing recommendations can be made in patients with renal impairment as
                                                this has not been studied),<sup>6</sup> rituximab (whose monograph notes
                                                that no
                                                pharmacokinetic data are available in renal insufficiency), tocilizumab (the
                                                monograph specifies that no dose adjustments are required in mild-moderate
                                                renal impairment while patients with severe renal impairment have not been
                                                studied) and abatacept (whose monograph, like that of infliximab, states
                                                that no dose recommendations can be made in renal impairment as this has not
                                                been studied).
                                            </p>
                                            <p>
                                                Tofacitinib may be used in patients who have an intolerance
                                                or have failed treatment with MTX and one other csDMARD,<sup>7</sup> but per
                                                the
                                                monograph this should be used with caution (and modified dosing) in patients
                                                with moderate or severe renal insufficiency. Tofacitinib should be avoided
                                                in patients who are at an increased risk of thrombosis,<sup>7</sup> and
                                                should be used
                                                with caution in older patients who are current or past smokers and patients
                                                with other CV or malignancy risk factors.<sup>8</sup> Health Canada has also
                                                initiated
                                                a new safety review of the other JAK inhibitors, upadacitinib and
                                                baricitinib, examining potential risks of serious heart-related problems,
                                                cancer and blood clots. Finally, according to its monograph, baricitinib
                                                does not require dose adjustment in mild renal impairment, but is not
                                                recommended in patients with moderate-to-severe renal impairment or ESRD.
                                            </p>
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div class="box-item diff-1">
                        <h3 class="common-title text-deeppink mb-3">
                            Luciana’s risk factors & comorbidities as part of the metabolic syndrome
                        </h3>
                        <div class="accordion-wrapper">
                            <div class="accordion--items">
                                <div class="accordion--item">
                                    <div class="accordion__title">
                                        <div class="accordion__title__inner">
                                            <h3>
                                                What are the indicators of metabolic syndrome in Luciana’s case? What are
                                                some other risk factors for metabolic syndrome?
                                            </h3>
                                            <img src="assets/images/icons/accordion-title.svg" alt="">
                                        </div>
                                    </div>
                                    <div class="accordion__content" style="height: 0px;">
                                        <div class="accordion__content__inner pt-3">
                                            <p>
                                                In Luciana’s case, indicators of the metabolic syndrome include elevated
                                                triglycerides, low HDL-C, hypertension, and borderline hyperglycemia, high
                                                BMI, centripetal obesity (elevated waist circumference).
                                            </p>
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div class="box-item diff-1">
                        <h3 class="common-title text-deeppink mb-3">
                            Other risk factors for metabolic syndrome in patients with RA:
                        </h3>
                        <p class="text-bold mb-2">
                            The potential impact of medications
                        </p>
                        <div class="accordion-wrapper">
                            <div class="accordion--items">
                                <div class="accordion--item">
                                    <div class="accordion__title">
                                        <div class="accordion__title__inner">
                                            <h3>
                                                What are some other factors/comorbidities for metabolic syndrome that should
                                                be considered in a patient with rheumatoid arthritis?
                                            </h3>
                                            <img src="assets/images/icons/accordion-title.svg" alt="">
                                        </div>
                                    </div>
                                    <div class="accordion__content" style="height: 0px;">
                                        <div class="accordion__content__inner pt-3">
                                            <p>
                                                Some medications, such as chronic low dose prednisone, duloxetine and
                                                pregabalin for pain, can increase weight. High daily calorie intake and lack
                                                of exercise causing weight gain can worsen fatty liver.
                                            </p>
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div class="box-item diff-1 diff">
                        <h3 class="common-title text-deeppink mb-3">
                            Communication between specialists
                        </h3>
                        <p class="mb-2 pb-2">
                            What messages would rheumatologists and cardiologists like to communicate to primary care
                            physicians about managing patients with RA with or at risk of metabolic syndrome, and how can
                            they best communicate their thoughts and plans to primary care physicians and to each other?

                        </p>
                        <p class="mb-3">
                            Click to see Dr. Pope’s answer.
                        </p>
                        <div class="position-relative mb-3 pb-1">
                            <video controls src="assets/videos/demo.mp4"></video>
                            <img src="assets/images/video/1.jpg" alt="">
                            <a href="#"
                               class="cursor-pointer position-absolute play-button  d-flex align-items-center justify-content-center">
                                <img src="assets/images/icons/play-2.svg" alt="">
                            </a>
                        </div>
                        <p class="my-3">
                            Click to see Dr. Tardif’s answer.
                        </p>
                        <div class="position-relative mb-2">
                            <video controls src="assets/videos/demo.mp4"></video>
                            <img src="assets/images/video/3.jpg" alt="">
                            <a href="#"
                               class="cursor-pointer position-absolute play-button  d-flex align-items-center justify-content-center">
                                <img src="assets/images/icons/play-2.svg" alt="">
                            </a>
                        </div>
                    </div>
                    <div class="box-item knowledge-test-box diff-1 two">
                        <div class="text-center">
                            <img src="assets/images/knowledge.svg" alt="">
                            <h3 class="common-title text-deeppink my-4 pt-1">
                                Patients with RA and/at risk for metabolic syndrome
                            </h3>
                            <div class="text-deeppink">
                                <span class="current-number">
                                    1
                                </span>
                                /
                                <span class="total-number">
                                    4
                                </span>
                            </div>
                        </div>
                        <div class="knowledge-test-questions">
                            <div class="knowledge-test-question active-item">
                                <p class="mt-3">
                                    In patients with RA with fatty liver:
                                </p>
                                <ul class="radio-options mt-3 bg-lightgray">
                                    <li class="d-flex align-items-center">
                                        <input type="radio" id="radio-4" name="q-1" class="me-1">
                                        <label for="radio-4">
                                            MTX is safe to use, regardless of other factors
                                        </label>
                                    </li>
                                    <li class="d-flex align-items-center">
                                        <input type="radio" id="radio-5" name="q-1" class="me-1">
                                        <label for="radio-5">
                                            MTX is not safe to use, regardless of other factors
                                        </label>
                                    </li>
                                    <li class="d-flex align-items-center">
                                        <input type="radio" id="radio-6" name="q-1" class="me-1">
                                        <label for="radio-6">
                                            MTX is safe to use if F score is F2 or less
                                        </label>
                                    </li>
                                    <li class="d-flex align-items-center">
                                        <input type="radio" id="radio-7" name="q-1" class="me-1">
                                        <label for="radio-7">
                                            MTX is safe to use if F score is F1 or less
                                        </label>
                                    </li>


                                </ul>
                            </div>
                            <div class="knowledge-test-question">
                                <p class="mt-3">
                                    MTX dose should be ____________ in patients with moderate chronic renal failure.
                                </p>
                                <ul class="radio-options mt-3 bg-lightgray">
                                    <li class="d-flex align-items-center">
                                        <input type="radio" id="radio-8" name="q-2" class="me-1">
                                        <label for="radio-8">
                                            Increased
                                        </label>
                                    </li>
                                    <li class="d-flex align-items-center">
                                        <input type="radio" id="radio-9" name="q-2" class="me-1">
                                        <label for="radio-9">
                                            Prescribed as in any other patient
                                        </label>
                                    </li>
                                    <li class="d-flex align-items-center">
                                        <input type="radio" id="radio-10" name="q-2" class="me-1">
                                        <label for="radio-10">
                                            Reduced
                                        </label>
                                    </li>
                                    <li class="d-flex align-items-center">
                                        <input type="radio" id="radio-11" name="q-2" class="me-1">
                                        <label for="radio-11">
                                            Eliminated
                                        </label>
                                    </li>
                                </ul>
                            </div>
                            <div class="knowledge-test-question">
                                <p class="mt-3">
                                    Which of the following medications can be associated with a significant increase in
                                    weight?
                                </p>
                                <ul class="radio-options mt-3 bg-lightgray">

                                    <li class="d-flex align-items-center">
                                        <input type="radio" id="radio-12" name="q-3" class="me-1">
                                        <label for="radio-12">
                                            a. MTX
                                        </label>
                                    </li>
                                    <li class="d-flex align-items-center">
                                        <input type="radio" id="radio-13" name="q-3" class="me-1">
                                        <label for="radio-13">
                                            b. Prednisone
                                        </label>
                                    </li>
                                    <li class="d-flex align-items-center">
                                        <input type="radio" id="radio-14" name="q-3" class="me-1">
                                        <label for="radio-14">
                                            c. Pregabalin
                                        </label>
                                    </li>
                                    <li class="d-flex align-items-center">
                                        <input type="radio" id="radio-15" name="q-3" class="me-1">
                                        <label for="radio-15">
                                            d. Duloxetine
                                        </label>
                                    </li>
                                    <li class="d-flex align-items-center">
                                        <input type="radio" id="radio-16" name="q-3" class="me-1">
                                        <label for="radio-16">
                                            e. all of the above

                                        </label>
                                    </li>
                                    <li class="d-flex align-items-center">
                                        <input type="radio" id="radio-17" name="q-3" class="me-1">
                                        <label for="radio-17">
                                            f. only b, c and d above
                                        </label>
                                    </li>
                                </ul>
                            </div>
                            <div class="knowledge-test-question">
                                <p class="mt-3">
                                    Which of the following conditions increase the risk of MACE?
                                </p>
                                <ul class="radio-options mt-3 bg-lightgray">
                                    <li class="d-flex align-items-center">
                                        <input type="radio" id="radio-18" name="q-4" class="me-1">
                                        <label for="radio-18">
                                            a. Chronic renal failure
                                        </label>
                                    </li>
                                    <li class="d-flex align-items-center">
                                        <input type="radio" id="radio-19" name="q-4" class="me-1">
                                        <label for="radio-19">
                                            b. Metabolic syndrome
                                        </label>
                                    </li>
                                    <li class="d-flex align-items-center">
                                        <input type="radio" id="radio-20" name="q-4" class="me-1">
                                        <label for="radio-20">
                                            c. RA </label>
                                    </li>
                                    <li class="d-flex align-items-center">
                                        <input type="radio" id="radio-21" name="q-4" class="me-1">
                                        <label for="radio-21">
                                            d. All of the above
                                        </label>
                                    </li>
                                    <li class="d-flex align-items-center">
                                        <input type="radio" id="radio-22" name="q-4" class="me-1">
                                        <label for="radio-22">
                                            e. only b and c above
                                        </label>
                                    </li>
                                </ul>
                            </div>
                        </div>
                        <div class="text-center mt-3 next-and-submit">
                            <a href="#" class="pink-button">Next</a>
                        </div>
                    </div>
                    <div id="references" class="box-item diff-1 references">
                        <h3 class="common-title text-deeppink mb-3">
                            References (RA and metabolic syndrome):
                        </h3>

                        <p class="mb-2">1. Sandrin L, Fourquet B, Hasquenoph JM, <i>et al</i>. Transient elastography: a new
                            noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29:1705-13.
                        </p>
                        <p class="mb-2">2. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury.
                            National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Methotrexate. Available
                            at: https://www.ncbi.nlm.nih.gov/books/NBK548219/. Accessed March 2022. </p>
                        <p class="mb-2">3. Wang W, Zhou H, Liu L. Side effects of methotraxate therapy for rheumatoid
                            arthritis: A systematic review. European Journal of Medicinal Chemistry 2018; 158(5):502-16.
                        </p>
                        <p class="mb-2">4. Erdbrügger U, de Groot K. Is methotrexate nephrotoxic? Dose-dependency,
                            comorbidities and comedication. Z Rheumatol 2011; 70(7):549-52.</p>
                        <p class="mb-2">5. Drosos A. Methotrexate intolerance in elderly patients with rheumatoid arthritis:
                            what are the alternatives? Drugs Aging 2003; 20(10):723-36. </p>
                        <p class="mb-2">6. Hammoudeh M. Infliximab treatment in a patient with rheumatoid arthritis on
                            haemodialysis. Rheumatology (Oxford) 2006; 45:357-9.</p>
                        <p class="mb-2">7. U.S. FDA. FDA requires warnings about increased risk of serious heart-related
                            events, cancer, blood clots, and death for JAK inhibitors that treat certain chronic
                            inflammatory conditions. Available at:
                            www.fda.gov/drugs/drug-safety-and-availability/fda-requires-warnings-about-increased-risk-serious-heart-related-events-cancer-blood-clots-and-death.
                            Accessed March 2022. </p>
                        <p class="mb-2">8. Health Canada. Health Canada safety review finds link between the use of Xeljanz
                            and Xeljanz XR (tofacitinib) and increased risk of serious heart-related issues and cancer.
                            Available at:
                            https://recalls-rappels.canada.ca/en/alert-recall/health-canada-safety-review-finds-link-between-use-xeljanz-and-xeljanz-xr-tofacitinib.
                            Accessed March 2022. </p>
                        <p class="mb-2">9. Remicade<sup>®</sup> (infliximab) product monograph. Janssen Inc. Revised October
                            15, 2021.</p>
                        <p class="mb-2">10. Ruxience (rituximab) product monograph. Pfizer Canada ULC. Revised July 8, 2020.
                        </p>
                        <p class="mb-2">11. Actemra<sup>®</sup> (tocilizumab) product monograph. Hoffman-La Roche Ltd.
                            Revised January 4, 2021.</p>
                        <p class="mb-2">12. Orencia<sup>®</sup> (abatacept) product monograph. Bristol-Myers Squibb. Revised
                            September 9, 2019.</p>
                        <p class="mb-2">13. Xeljanz<sup>®</sup> (tofacitinib) product monograph. Pfizer Canada ULC. Revised
                            December 9, 2021.</p>

                    </div>

                </div>
                <div class="right-sidebar">
                    <div class="box-item">
                        <div class="rs-content">
                            <h3 class="text-deeppink border-bottom mb-3">
                                Luciana at a glance
                            </h3>
                            <div class="rs-list mb-3">
                                <h4 class="text-bold">
                                    Physical exam
                                </h4>
                                <ul class="bullet-point">
                                    <li>Height 158 cm</li>
                                    <li>Weight 90 kg (BMI 36.1 kg/m<sup>2</sup>)</li>
                                    <li>BP 135/90 mmHg</li>

                                </ul>
                            </div>
                            <div class="rs-list mb-3">
                                <h4 class="text-bold">
                                    Lab values
                                </h4>
                                <ul class="bullet-point">

                                    <li>FBS 6.0 mmol/L</li>
                                    <li>TG 1.8 mmol/L</li>
                                    <li>HDL-C 1.0 mmol/L</li>
                                    <li>Creatinine 135 µmol/L</li>

                                </ul>
                            </div>
                            <div class="rs-list mb-3">
                                <h4 class="text-bold">
                                    Pertinent medical <br>
                                    & family history
                                </h4>
                                <ul class="bullet-point">

                                    <li>
                                        RA for 6 years, stable on MTX and
                                        hydroxychloroquine
                                    </li>
                                    <li>Obesity, hypertension</li>
                                    <li>Borderline hyperglycemia</li>
                                    <li>Type 2 diabetes; dyslipidemia</li>
                                    <li>Fatty liver</li>
                                    <li>Mother: type 2 diabetes</li>


                                </ul>
                            </div>
                            <div class="rs-list mb-3">
                                <h4 class="text-bold">
                                    Other pertinent history
                                </h4>
                                <ul class="bullet-point">
                                    <li>
                                        Former heavy smoker
                                        (25 years; quit one year ago)
                                    </li>
                                    <li>
                                        No exercise
                                    </li>
                                    <li>Occasionally cooks, but mostly eats at
                                        work cafeteria</li>

                                </ul>
                            </div>
                            <div class="rs-list mb-3">
                                <h4 class="text-bold">
                                    Current medications
                                </h4>
                                <ul class="bullet-point">
                                    <li>MTX + hydroxychloroquine</li>
                                    <li>Statin</li>
                                    <li>ACE inhibitor + diuretic + beta blocker</li>
                                </ul>
                            </div>

                        </div>
                    </div>
                </div>
            </div>
        </section>
        <footer>
            <div class="container">
                <p class="text-white">
                    Copyright 2022. This learning program is supported by Pfizer Canada. The faculty had full editorial
                    control over the contents of the program. The contents of the program are aligned with the approved
                    Canadian product monographs. Opinions expressed are those of the presenters and not necessarily Pfizer
                    Canada. This program is intended for healthcare professionals only.
                </p>
            </div>
        </footer>



        <script src="assets/js/jquery.min.js"></script>
        <script src="assets/js/bootstrap.bundle.min.js"></script>
        <script src="assets/js/index.js"></script>
    </body>

</html>